about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesHepatocellular carcinoma: Review of disease and tumor biomarkersCirculating bile acids predict outcome in critically ill patients.The Impact of Sterile Inflammation in Acute Liver Injury.Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice.Effects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and agonist-induced contraction in rat resistance arteriesIntegrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure.Serum bile acids in the diagnosis of hepatobiliary disease.Physiological factors influencing serum bile acid levelsLiver structure and function in cholelithiasis: effect of chenodeoxycholic acidBile acid metabolism in infants and children.Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).Bile acids regulate nuclear receptor (Nur77) expression and intracellular location to control proliferation and apoptosis.Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension.Diagnositic value of serum bile acid estimations in liver disease.A synthetic biology-based device prevents liver injury in miceBile acids activate YAP to promote liver carcinogenesis.Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells.Bile acid homeostasis controls CAR signaling pathways in mouse testis through FXRalpha.Bile acids and cardiovascular function in cirrhosis.Effect of oral contraception on serum bile acid.Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.Inhibition of interferon-α-induced signaling by hyperosmolarity and hydrophobic bile acids.Serum bile acids in hepatobiliary disease.Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage.Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes.Serum bile acids in primary biliary cirrhosisBile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages.Profiles of serum bile acids in liver diseasesBile acids induce arrhythmias: old metabolite, new tricks.Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease.Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.Metabonomics analysis of serum from rats given long-term and low-level cadmium by ultra-performance liquid chromatography-mass spectrometry.Bioanalysis of ibrutinib and its active metabolite in human plasma: selectivity issue, impact assessment and resolution.Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart.Lack of an effect of multivitamins containing vitamin A on serum retinyl esters and liver function tests in healthy women.
P2860
Q26741550-26836825-FBFC-4CD0-A75A-76F56DAD12EAQ26750796-B5FCB35C-E6BD-4CE5-882D-492A04519867Q33627590-05287106-03CF-4831-A382-6428649A892FQ33847610-72C68DA8-2C1F-4F22-8284-5C8A2CC46732Q33870953-0E077B9F-EA08-4184-8C48-32C19D2F412AQ34168512-E5EFDD3A-5A92-47A4-98C5-ECA12A9F90AEQ34214476-F0D8AF9C-A414-4F24-8800-CE7FA69F7E8DQ34473379-78AEC4E3-E0A3-4B8C-811A-8DECE7ACE57EQ34473665-F66792FB-8EF3-4D93-B06E-E44C7AB3677BQ34473785-21B47280-43E3-4452-ADD2-7AD67B5F3F16Q34476715-0F4AE53E-8278-4DBD-B18F-9B727D6BC7BEQ34476750-067AB27D-DC23-4A41-9FD1-5F73F38736B9Q34493993-340276F4-C107-4948-A3DE-732845401808Q35043978-BC069407-C044-45DF-8938-7F5718C09C00Q35108902-45A535F3-D2E2-4C5F-8DD3-FAF9A5123475Q35783812-586DC893-6E5C-433D-88E7-8A07ED077CCBQ36590667-B5F63A81-3000-4463-8706-208FF7933519Q37023678-E57F4130-AC34-4FB6-919F-939C6C4B2A28Q37651886-9A56DEC1-68CD-451E-9D66-9266C3F0149BQ38397273-0AC42E1F-45CE-4B7F-A23B-A36F01C0AB2BQ38866694-A4466BA3-8F8C-4FBB-97CB-01C1882E6818Q38970278-7C04ED2B-543E-4181-B8BA-000FFCD6518DQ39145368-8E1E23E9-D04D-42DE-A030-584DC2DA6BF5Q39448685-D98336FB-5F01-450E-A332-60604337C710Q39602278-DFDCCAD7-F488-49EA-BA91-2705619798E7Q39638816-C6B9E29F-D89A-40B1-9B75-065DC56AFB82Q39762366-89C742C7-AA3D-45AC-B830-ECCDA64B7854Q41785704-6D9A9798-D899-4513-A4B2-775B4E892E6EQ41816124-F67BB62C-5778-4D3A-AD1A-D212B58BB35AQ41876134-D64D4CB9-981E-4630-892A-9F9DBCBC8176Q42249372-595789F0-9E86-4E4D-88C7-C74DB02D2092Q42498996-14D1A47C-B688-43DB-9548-39826D12D9A5Q42623395-2DC5FD4E-93F5-4FAC-9550-026472075400Q43996671-A5494FBC-5A1F-4B9F-89C2-9A1AB014FF59Q47107001-FFE6CCCC-876B-4964-89D2-7FDFEE30C655Q47135121-F9CF7FBE-4D2B-42A9-8020-01C5050A23F8Q47588081-D46D1EA0-956A-4174-A1C3-DCA846F0BBE3Q47977912-5402F949-55C1-4EA6-8946-53881A2D1BF9Q50301039-EEDA44AA-D75D-4DF4-B419-1E2BD8880454Q51603203-3733F468-2B75-4B37-A281-CF1D78B4183B
P2860
description
1971 nî lūn-bûn
@nan
1971 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1971 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
name
Serum bile acids in liver disease
@ast
Serum bile acids in liver disease
@en
Serum bile acids in liver disease
@nl
type
label
Serum bile acids in liver disease
@ast
Serum bile acids in liver disease
@en
Serum bile acids in liver disease
@nl
prefLabel
Serum bile acids in liver disease
@ast
Serum bile acids in liver disease
@en
Serum bile acids in liver disease
@nl
P2093
P2860
P356
P1433
P1476
Serum bile acids in liver disease
@en
P2093
P2860
P304
P356
10.1136/GUT.12.2.145
P407
P577
1971-02-01T00:00:00Z